Author: Andrew A. Lover
Title: Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020) Document date: 2020_3_27
ID: azvbl4ie_13
Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint To assess the secondary outcome, Kaplan-Meier and Cox models were use initially to compare the time-to-event with adjustment for covariates. Due severe proportional hazard violations in the HCQ-AZ group, flexible parametric models were used to estimate effects......
Document: is the (which was not peer-reviewed) The copyright holder for this preprint To assess the secondary outcome, Kaplan-Meier and Cox models were use initially to compare the time-to-event with adjustment for covariates. Due severe proportional hazard violations in the HCQ-AZ group, flexible parametric models were used to estimate effects.
Search related documents:
Co phrase search for related documents- covariate adjustment and secondary outcome: 1, 2
- covariate adjustment event time and event time: 1
- effect estimate and event time: 1, 2
- effect estimate and parametric model: 1
- effect estimate and secondary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- event time and parametric model: 1, 2
- event time and secondary outcome: 1, 2, 3, 4, 5, 6, 7
- flexible parametric model and parametric model: 1, 2
Co phrase search for related documents, hyperlinks ordered by date